Rolando Barajas, M.P.H.
Cancer Research Training Award Fellow, Genomic Epidemiology Branch, Epidemiology and Genomics Research Program

Contact Information

Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E120, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)

Interest Areas

  • Gene-environment interaction
  • Health disparities
  • Community-based participatory research
  • Environmental health


  • M.P.H. – Epidemiology & Maternal and Child Health
    San Diego State University
  • B.S. – Human Biology
    Michigan State University


Mr. Rolando Barajas is a Cancer Research Training Award (CRTA) fellow in the Epidemiology and Genomics Research Program's (EGRP) Genomic Epidemiology Branch (GEB). In this capacity, he assists with the development and evaluation of scientific initiatives and literature reviews for areas relevant to EGRP and GEB, including health disparities, rare cancers, and utilization of next-generation sequencing and existing genomic and epidemiologic datasets for population-based cancer research.

Prior to joining NIH, Mr. Barajas worked as the project coordinator for a longitudinal study/public health surveillance resource for the city of Flint through Michigan State University’s Flint Center for Health Equity Solutions. His work focused heavily on community-based participatory research due to the social climate of Flint following the water crisis. While completing his M.P.H. in Epidemiology from the University of California, San Diego (UCSD), he worked as a Clinical Research Coordinator at the UCSD Moores Cancer Center Neuro-oncology clinical trials team.

His research interests include evaluating cancer health disparities among minority groups, genetic cancer risk susceptibility and how it is impacted by the environment, and genetic differences within underserved populations that could improve treatment responses. He hopes to one day pursue his M.D. and Ph.D.

Return to Top